Merit medical announces acquisition of dialysis catheter portfolio and the biosentry® biopsy tract sealant system from angiodynamics, inc. and acquisition of the surfacer® inside-out® access catheter system from bluegrass vascular technologies, inc.

South jordan, utah, june 08, 2023 (globe newswire) -- merit medical systems, inc. (nasdaq: mmsi), a leading global manufacturer and marketer of healthcare technology, today announced it has completed the acquisition of a portfolio of dialysis catheter products and the biosentry® biopsy tract sealant system from angiodynamics, inc. for a total cash consideration of $100 million. merit also announced the recent acquisition of the surfacer® inside-out® access catheter system from bluegrass vascular technologies, inc. for a total cash consideration of $32.5 million.
MMSI Ratings Summary
MMSI Quant Ranking